Screener
Ligand Pharmaceuticals LGND Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|
| Purchases of short-term investments | (259,327) | (122,717) |
| Proceeds from sale of short-term investments | 242,563 | 38,414 |
| Proceeds from maturity of short-term investments | 239,805 | 83,220 |
| Purchases of other investments | (1,250) | — |
| Net cash provided by (used in) investing activities | 226,770 | (5,773) |
| Cash flows from financing activities: | ||
| Gross proceeds from issuance of Convertible Senior Notes | 700,000 | — |
| Debt discount and payment of debt issuance cost | (20,175) | (73) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's investing cash flow?
- Ligand Pharmaceuticals (LGND) reported investing cash flow of $321.12M in Q2 2026.
- How has Ligand Pharmaceuticals's investing cash flow changed year-over-year?
- Ligand Pharmaceuticals's investing cash flow increased by 3110.4% year-over-year, from -$10.67M to $321.12M.
- What is the long-term trend for Ligand Pharmaceuticals's investing cash flow?
- Over 3 years (2022 to 2025), Ligand Pharmaceuticals's investing cash flow has grown at a 30.2% compound annual growth rate (CAGR), from $170.91M to -$377.32M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Ligand Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude